BioSpace News Archive

The International Myeloma Foundation’s Black Swan Research Initiative® proudly showcased four oral and two poster abstracts from the iStopMM Project during the 65th American Society of Hematology Annual Meeting in San Diego, CA which took place from December 9-12, 2023.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that it will host an Investor Business Forum and Long-Term Outlook Call on Wednesday, January 17, 2024 at 5:30 a.m. PT / 8:30 a.m. ET.

Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced successful completion of an animal safety study evaluating the Company’s proprietary ablation technology.

Every January, the global medical health and financial investment sectors turn their focus to San Francisco.

PumasAI, a pioneering organization at the forefront of transforming data into life-saving decisions with remarkable speed, is proud to announce the appointment of two distinguished leaders to its team.

Gold Colloid Co., a leading distributor of medical and diagnostic products in the United States, announced today a strategic partnership with Hangzhou Clongene Biotech Co., Ltd., a renowned Chinese manufacturer of in-vitro diagnostic (IVD) rapid tests and raw materials.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) submitted a comment letter (here) on January 5, 2024, regarding the FDA’s recently announced policy—by way of a draft guidance document—that substantially restricts drug manufacturers’ ability to communicate truthful, non-misleading information about FDA-approved drugs.

Centene Corporation announced today it has completed the previously announced divestiture of Circle Health Group, one of the U.K.'s largest independent operators of hospitals, to Pure Health, the largest integrated healthcare network in the Middle East.

Glaucoma Research Foundation President and CEO, Thomas M. Brunner announced the 2024 Annual Gala honorees including philanthropists Judy and Charles Munnerlyn, visionary donors and glaucoma advocates The Zander Family, and artist and patient advocate Patricia Caulfield.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.